MOUNTAIN VIEW, Calif.--(www.janmedical.com) announced today that patients have been enrolled in an outpatient clinical study — directed by Paul S. Auerbach, M.D., of Stanford University Medical Center — of the Company’s Nautilus NeuroWave™ portable continuous brain-sensing system. Dr. Auerbach is the Redlich Family Professor of Surgery in the Division of Emergency Medicine. He has been recognized as a “Hero of Emergency Medicine” by the American College of Emergency Physicians.)--Jan Medical (
“We are hopeful that our Nautilus NeuroWaveTM system can rapidly provide definitive information about patients presenting with concussion symptoms”
The study is expected to be completed this fall with enrollment of high school football players. The study involving this enrollee cohort will further efforts to validate the Nautilus NeuroWaveTM system’s ability to detect a unique “signature” that strongly correlates with signs and symptoms and a standard scoring system associated with concussions. The data will also be analyzed to determine if and how signature resolution correlates with resolution of the clinical concussion syndrome.
Roughly every 21 seconds someone in the United States suffers a significant brain injury, such as a concussion. Among the most common causes of concussions are sports injuries, even with the use of protective headgear. People also receive concussions from falls, car accidents, bicycling mishaps, and physical violence. People who receive a second head injury prior to resolution of an existing concussion syndrome may be more prone to residual brain damage, which makes it particularly important to accurately determine the presence or absence of resolution. There is currently no technology to diagnose the onset of a concussion or its resolution.
“The compact size of the Jan Medical system makes it portable, which is ideal for use on the athletic sideline or in the locker room, within an ambulance or Emergency Department, and in support of battlefield operations,” said Dr. Auerbach.
“We are hopeful that our Nautilus NeuroWaveTM system can rapidly provide definitive information about patients presenting with concussion symptoms,” added Paul Lovoi, Ph.D., CEO of Jan Medical. “If this study demonstrates that our portable brain-sensing system is able to rapidly and non-invasively detect the onset and offset of concussions, we plan to move prudently to a large multi-center trial.”
Jan Medical is a privately held, emerging medical technology company that has developed the world’s first and only portable brain sensing system designed to rapidly diagnose and aid assessment of strokes.
CAUTION: THE JAN MEDICAL SYSTEM IS AN INVESTIGATIONAL DEVICE, LIMITED BY FEDERAL (UNITED STATES) LAW TO INVESTIGATIONAL USE.